Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet

摘要

The invention refers to the use of sulfated glycosaminoglycans having an anticoagulant activity of 100 BP units/mg or less for the manufacture of a pharmaceutical preparation for prophylactic priming or curative treatment of the cervix and the myometrium for establishing effective labor in women.